Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BLISS GVS PHARMA vs RAYMED LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BLISS GVS PHARMA RAYMED LABS BLISS GVS PHARMA/
RAYMED LABS
 
P/E (TTM) x 13.1 -7.1 - View Chart
P/BV x 1.3 - - View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 BLISS GVS PHARMA   RAYMED LABS
EQUITY SHARE DATA
    BLISS GVS PHARMA
Mar-23
RAYMED LABS
Mar-23
BLISS GVS PHARMA/
RAYMED LABS
5-Yr Chart
Click to enlarge
High Rs912 4,477.9%   
Low Rs671 4,516.8%   
Sales per share (Unadj.) Rs72.20-  
Earnings per share (Unadj.) Rs7.4-0.4 -1,839.8%  
Cash flow per share (Unadj.) Rs9.2-0.4 -2,370.7%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs84.0-5.4 -1,555.7%  
Shares outstanding (eoy) m104.154.27 2,439.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.10-  
Avg P/E ratio x10.8-4.4 -244.1%  
P/CF ratio (eoy) x8.7-4.6 -190.0%  
Price / Book Value ratio x0.9-0.3 -288.7%  
Dividend payout %6.80-   
Avg Mkt Cap Rs m8,2628 109,538.1%   
No. of employees `000NANA-   
Total wages/salary Rs m8620 226,755.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7,5160-  
Other income Rs m1780 84,695.2%   
Total revenues Rs m7,6940 3,663,685.7%   
Gross profit Rs m1,173-2 -63,076.9%  
Depreciation Rs m1870 373,460.0%   
Interest Rs m1040-   
Profit before tax Rs m1,061-2 -62,030.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2930-   
Profit after tax Rs m767-2 -44,874.3%  
Gross profit margin %15.60- 
Effective tax rate %27.70-   
Net profit margin %10.20- 
BALANCE SHEET DATA
Current assets Rs m6,9740 13,947,320.0%   
Current liabilities Rs m1,9331 214,732.2%   
Net working cap to sales %67.10- 
Current ratio x3.60.1 6,495.2%  
Inventory Days Days390- 
Debtors Days Days1,8710- 
Net fixed assets Rs m4,5622 302,088.7%   
Share capital Rs m10443 243.7%   
"Free" reserves Rs m8,646-66 -13,141.6%   
Net worth Rs m8,750-23 -37,944.6%   
Long term debt Rs m4070-   
Total assets Rs m11,5352 739,435.9%  
Interest coverage x11.20-  
Debt to equity ratio x00-  
Sales to assets ratio x0.70-   
Return on assets %7.6-109.5 -6.9%  
Return on equity %8.87.4 118.3%  
Return on capital %12.77.4 171.7%  
Exports to sales %00-  
Imports to sales %00-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,6180-   
Fx outflow Rs m1,2250-   
Net fx Rs m4,3940-   
CASH FLOW
From Operations Rs m343-2 -20,923.2%  
From Investments Rs m-782 -4,726.2%  
From Financial Activity Rs m-249NA-  
Net Cashflow Rs m300-  

Share Holding

Indian Promoters % 35.0 28.4 123.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 22.0 1.0 2,287.5%  
FIIs % 15.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.0 71.6 90.8%  
Shareholders   40,758 1,498 2,720.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BLISS GVS PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BLISS GVS PHARMA vs RAYMED LABS.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BLISS GVS PHARMA vs RAYMED LABS. Share Price Performance

Period BLISS GVS PHARMA RAYMED LABS. S&P BSE HEALTHCARE
1-Day -1.31% 0.00% 1.18%
1-Month -9.12% 3.32% -0.75%
1-Year 58.26% 6.86% 61.82%
3-Year CAGR 3.89% 31.90% 18.16%
5-Year CAGR -8.75% -1.90% 19.79%

* Compound Annual Growth Rate

Here are more details on the BLISS GVS PHARMA share price and the RAYMED LABS. share price.

Moving on to shareholding structures...

The promoters of BLISS GVS PHARMA hold a 35.0% stake in the company. In case of RAYMED LABS. the stake stands at 28.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BLISS GVS PHARMA and the shareholding pattern of RAYMED LABS..

Finally, a word on dividends...

In the most recent financial year, BLISS GVS PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.8%.

RAYMED LABS. paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of BLISS GVS PHARMA, and the dividend history of RAYMED LABS..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.